Ruixuan Jiang

8PUBLICATIONS
22CO-AUTHORS
Epidemiological methodsSensory processes, perception and performancePredictive and prognostic markersMedical infection agents (incl. prions)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 02, 2024
The economic burden of recurrence in elderly patients with completely resected, stage IIB/IIC or III melanoma: an analysis of the Surveillance, Epidemiology, and End Results-Medicare linked database.

Ruixuan Jiang, Travis Wang, Yue Liu

|May 18, 2023
Comparison of Preferences and Data Quality between Discrete Choice Experiments Conducted in Online and Face-to-Face Respondents.

Ruixuan Jiang, Eleanor Pullenayegum, James W Shaw

|Feb 07, 2023
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.

Andrea Favre-Bulle, Goran Bencina, Shujing Zhang

|Dec 23, 2022
Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review.

Xiang-Lin Tan, Amy Le, Huilin Tang

|Sep 09, 2022
EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets.

Ruixuan Jiang, Kim Rand, Maja Kuharic

|Apr 12, 2022
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany.

Peter Mohr, Emilie Scherrer, Chalid Assaf

Pageof 2

Frequent Collaborators

1 joint publications

Thomas Eigentler

1 joint publications

Ralf Gutzmer

1 joint publications

Jessica C Hassel

1 joint publications

Axel Hauschild